PHARMACOVIGILANCE AGREEMENT Between Neurelis, Inc.Pharmacovigilance Agreement • October 18th, 2020 • California
Contract Type FiledOctober 18th, 2020 JurisdictionThis Pharmacovigilance Agreement (“PVA”) is made and entered into with an effective date of DDMMYYYY between Neurelis, Inc. (“Neurelis”) and CMS (“CMS”) in order to comply with pharmacovigilance and regulatory responsibilities. Neurelis, Inc. and CMS may hereinafter be referred to individually as a “Party” or collectively as the “Parties”.